TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 0 | -1 | -6 | 41 | 95 | 58 | 38 |
| P | %wins | 100 | 50 | 50 | 100 | 100 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/8/12 17:56 | 5/4/12 | SUPN | Supernus Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Abingworth Management Ltd | X0 | T | P.d | 5,500 | 5.00 | 1 | 1,100 | 44 | 3,600 | I | 11 | 0 | -2 | -30 | 80 | 91 | -24 | ||||||||
8/15/05 18:25 | 8/11/05 | XGEN | Xenogen Corp | DE | Electr | LabEq | Measuring & Controlling Devic | Abingworth Management Ltd | X0 | T | P.d | 4,000 | 2.91 | 0 | 1,375 | 79 | 3,121 | I | |||||||||||||||
7/14/05 14:47 | 7/12/05 | SLXA | Solexa, Inc. | DE | Health | MdCm | Medicinal Chemicals & Botanic | Abingworth Management Ltd | X0 | T | P.d | 3,319 | 4.00 | 0 | 830 | 37 | 3,057 | I | |||||||||||||||
3/10/05 10:18 | 5/27/04 | ALNY | Alnylam Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Abingworth Management Ltd | T | P.a | 783 | 6.00 | 1 | 131 | 525 | 155 | I | 17 | 2 | -2 | -5 | -3 | 0 | 0 | 1 | 19 | 2 | 99 | 140 | |||||
6/1/04 18:57 | 5/27/04 | ALNY | Alnylam Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Abingworth Management Ltd | T | P.e | 1,560 | 6.00 | 0 | 260 | 2 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |